Navigation Links
GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
Date:11/10/2008

s are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.

Third Quarter Operational Highlights:

* On October 22, 2008, Dr. Robert McNally, GeoVax's President and CEO,

was the featured interview on the Wall St. Network's 3-Minute Press

Show, a daily program that features in-depth interviews with public

company executives. The interview may be viewed in its entirety at

http://www.tv.wallst.net/r/3-minute-press/Bob-McNally-GOVX-BB/306/1207.

* On October 31, 2008, an additional interview with Dr. McNally was

published by CEOCFO Interviews & News

(http://www.ceocfointerviews.com). Also, GeoVax was prominently

featured in a special Biotechnology supplement to the November issue

of Harvard Business Review, sponsored by the Michigan Economic

Development Corp (MEDC).

* On October 20, 2008, GeoVax announced shipment of both components

(DNA and MVA) of its AIDS vaccine to the HIV Vaccine Trials Network

(HVTN) pharmacy, for use in the upcoming Phase 2a human clinical

trial. GeoVax also announced the submission of a Biological Master

File Amendment to the U.S. Food and Drug Administration (FDA) for

review of the manufacturing data for the product shipped to HVTN.

The Phase 2a trial will be conducted by the HVTN and will involve

225 healthy volunteers from the United States and South America. The

trial will further evaluate the safety and immunogenicity of the

GeoVax preventative vaccine (vaccine administered prior to infection

with the HIV virus) and will broaden the base of safety and

immunogenicit
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update
2. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
3. GeoVax Further Strengthens Management Team
4. GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
5. GeoVax Labs, Inc. Information To Be Available Through Standard & Poors Market Access Program
6. GeoVax Presents Data at AIDS Vaccine 2008 Conference
7. GeoVaxs DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., , PARIS, November 27 /PRNewswire-Fi... approval to market Oralair(R) in both adults and ...ermany, the first country where,Oralair(R) has bee... Oralair(R) is now registered in Austria, Belg..., France, Germany, Greece, Hungary, Ireland, Italy...
(Date:11/25/2009)..., , BOSTON, Nov. 25 ...he H1N1 virus, genomic data from the 1918 pandemic... the current H1N1 pandemic, today issued its lates...shows that the lethality of the H1N1 ("Swine Flu")... during the virus,s current outbreak in the spring...
(Date:11/25/2009)..., , BEIJING, Nov. 25 /PRNewswi... developer and provider of vaccines, announced tod... to establish Sinovac (Dalian) Vaccine,Technology ...develop, produce,and commercialize human-use vacci...erience in developing and commercializing world-cl...
(Date:11/24/2009)..., , HOUSTON, Nov. 24 /PRNewswire-Firs... provider of electrical and communications systems...esidential markets, announced today that its comme...rom Manhattan Torcon JV to install the electrical ...lacement facility at the U.S. Army Medical Researc...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...ealth Software Will be Core Application for M... Programs, WASHINGTON, Nov. 5 Netsmart Technolog...oftware and services for health and,human services...greement to,implement its public health software a...ent of Health and Wellness Promotion (DHWP). The,a...
...ients on TPI 287 show clinical benefit, BOULDER, ...daq: TPPH ) announced today financial results for...net loss for the third quarter of 2007 was $6.1 mi...loss for the third quarter of 2006 of,$3.6 million... the third,quarter of 2007 and 2006 is non-cash eq...
...ep closer to understanding the atomic forces that ...dy by researchers from the University of Pennsylva...ment of Energy,s Argonne National Laboratory. , T...ty of Pennsylvania, found a significant difference...d been coated with different isotopes of hydrogen ...
Other Biology Technology:Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software 2Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 2Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 3Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 4Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 5Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 6Tapestry Reports Third Quarter 2007 Financial Results and Preliminary Data From Its Phase 2 Prostate Cancer Trial 7Heavier hydrogen on the atomic scale reduces friction 2
(Date:11/24/2009)...at may help gut bacteria bind to the gastrointesti...producers to identify strains that are likely to b...o interact with cells lining the gut to have a ben...the gut they are more likely to stick around long ...Juge from the Institute of Food Research. IFR is ...
(Date:11/24/2009)...lass of ring-shaped protein motors has been uncove...onal Laboratory (Berkeley Lab) using a state-of-th...nced Light Source (ALS). These protein motors play... and are vital to the survival of all biological c...man papillomavirus, which has been linked to cervi...
(Date:11/24/2009)...09) -- The Wildlife Conservation Society (WCS) ann...ining population of Siberian tigers has likely dec...hing and habitat loss. , WCS says th...t needs to be done to protect remaining population... report was released by the Siberian Tiger Monitor...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Report shows dramatic decline in Siberian tigers 2TV bombards children with commercials for high fat and high sugar foods 10639 1TV bombards children with commercials for high fat and high sugar foods 10639 2TV bombards children with commercials for high fat and high sugar foods 10639 3Will New Anemia Drug Top Current Treatments 3F 60717 1Will New Anemia Drug Top Current Treatments 3F 60717 2Will New Anemia Drug Top Current Treatments 3F 60717 3New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 60714 1New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 60714 2New HPV Vaccine Might Stop Vulvar Cancer in its Tracks 60714 3
...n Americans have peripheral arterial disease (PAD)...ions include African-Americans (twice as likely to...cent develop PAD) and diabetics (one in three who ...a community health and public information programr...ne self-assessment quiz. , The online quiz ( www....
...Large flightless birds of the southern continents ...s, South American rheas and the New Zealand kiwi ...believed. , Instead, each species individually lo...did have the ability to fly, according to new rese...ology professor Edward Braun. , The new research,...
...belt , Dust is one of several types of aerosols ...orly understood ways. Dust scatters and absorbs so...also interact with cloud formation and other clima...l Lidar and Infrared Pathfinder Satellite Observat...ving understanding of how clouds and aerosols inte...
Other Biology News:At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 2At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better 3New research challenges long-held assumptions of flightless bird evolution 2AGU journal highlights -- Sept. 3, 2008 2AGU journal highlights -- Sept. 3, 2008 3AGU journal highlights -- Sept. 3, 2008 4AGU journal highlights -- Sept. 3, 2008 5AGU journal highlights -- Sept. 3, 2008 6AGU journal highlights -- Sept. 3, 2008 7
...which belong to the transforming growth factor- (T...group of extra-cellular growth factors which contr...ion and tumor formation (1). Other members incude ...ntiation factors, AMH/MIS (Anti-Mullerian Hormone/...
...which belong to the transforming growth factor- (T...group of extra-cellular growth factors which contr...ion and tumor formation (1). Other members incude ...ntiation factors, AMH/MIS (Anti-Mullerian Hormone/...
...plating in just seconds , No need for glass rods...uniform spreading and more colonies, Two choices ...e for spreading 100 plates or single-use tubes for...ells on multiple plates simultaneously ,EZ-Sprea...
Silencer siRNA Starter Kit from Ambion
Biology Products: